Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1377, 2003-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
OCs: benefits outweigh adverse effects for cancer risk
Reactions Weekly, Vol. 1, Iss. 1121, 2006-01 ,pp. :
Access to resources
Recommend
Iodine Supplementation: Benefits Outweigh Risks
By Delange F.
Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. :
Myocardial Infarction in the Elderly: Benefits and Risks of Thrombolytics
By Aronow W.S.
Drug Safety, Vol. 25, Iss. 11, 2002-01 ,pp. :
Ezetimibe/simvastatin provides VYTAL benefits in diabetic patients
Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. :